Antiplatelet therapy to prevent stroke: Risk of brain hemorrhage and efficacy in atrial fibrillation [1] (multiple letters)

Journal of the Neurological Sciences

Volumn 153, Issue 1, 1997, Pages

  Benavente, O ^a   Hart, R G ^a   Diener, H C ^a   Lowenthal, A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; PLACEBO;

BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; THROMBOSIS PREVENTION;

ATRIAL FIBRILLATION; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS;

EID: 0031444570     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)